MRSA - hygiene management, diagnostics and treatment

被引:1
|
作者
Wagener, J. [1 ]
Seybold, U. [2 ]
机构
[1] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany
[2] Univ Munich, Klinikum Univ, Med Klin & Poliklin 4, Sekt Klin Infektiol, D-80336 Munich, Germany
关键词
Methicillin-resistente; Staphylococcus aureus (MRSA); Kolonisation; Search-; Destroy-; Follow-up-Strategie; Mupirocin; Vancomycin; methicillin-resistant; staphylococcus aureus (MRSA); colonization; search; destroy; follow-up strategy; mupirocin; vancomycin; RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL COLONIZATION; VANCOMYCIN-INTERMEDIATE; INFECTIONS; ERADICATION; PREVALENCE; BACTEREMIA; MECHANISMS; MUPIROCIN;
D O I
10.1055/s-0033-1359924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methicillin-resistant Staphyococcus aureus strains remain a challenge to both patient care and infection control efforts. In addition to the defining resistance to beta-lactams several other antibiotic classes may be ineffective. Some resistance phenotypes exhibit a characteristic distribution pattern between healthcare-associated, community-associated, and livestock-associated MRSA strains. For patients with defined risk factors a search-, destroy-, follow-up-strategy is recommended in order to identify and eliminate MRSA colonization. Mupirocin nasal ointment and extensive hygiene measures are the mainstays of decolonization efforts. Besides vancomycin several other antimicrobials such as rifampin, trimethoprim-sulfamethoxazol, clindamycin, linezolid, and daptomycin are used to treat specific MRSA infections.
引用
收藏
页码:643 / 654
页数:12
相关论文
共 50 条
  • [1] Cost comparison of MRSA screening and management - a decision tree analysis
    Tuebbicke, Andrea
    Huebner, Claudia
    Huebner, Nils-Olaf
    Wegner, Christian
    Kramer, Axel
    Flessa, Steffen
    BMC HEALTH SERVICES RESEARCH, 2012, 12
  • [2] Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment
    Hassoun, Ali
    Linden, Peter K.
    Friedman, Bruce
    CRITICAL CARE, 2017, 21 : 211
  • [3] Treatment options for nosocomial pneumonia due to MRSA
    Niederman, Michael S.
    JOURNAL OF INFECTION, 2009, 59 : S25 - S31
  • [4] The role of telavancin in the treatment of MRSA infections in hospital
    Bassetti, Matteo
    Mikulska, Malgorzata
    Righi, Elda
    Nicolini, Laura
    Viscoli, Claudio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 521 - 529
  • [5] Diagnosis and management of community-associated MRSA infections in children
    Long, Caroline B.
    Madan, Rebecca P.
    Herold, Betsy C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (02) : 183 - 195
  • [6] Management of MRSA/GISA, VISA Endocarditis
    Jacqueline, Cedric
    Caillon, Jocelyne
    Boutoille, David
    CURRENT INFECTIOUS DISEASE REPORTS, 2013, 15 (04) : 329 - 334
  • [7] TREATMENT PARADIGMS FOR MRSA
    Miller, Loren
    PEDIATRIC PULMONOLOGY, 2011, : 139 - 141
  • [8] MRSA in Croatia: prevalence and management
    Budimir, Ana
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (02) : 167 - 176
  • [9] Molecular diagnostics and genotyping of MRSA: an update
    Witt, Rene Te
    van Belkum, Alex
    van Leeuwen, Willem B.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (04) : 375 - 380
  • [10] Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study
    Watanabe, Akira
    Goto, Hajime
    Soma, Kazui
    Kikuchi, Toshiaki
    Gomi, Kazunori
    Miki, Hiroshi
    Maemondo, Makoto
    Ikeda, Hideki
    Kuroki, Jun
    Wada, Hiroo
    Yokoyama, Takuma
    Izumi, Shinyu
    Mitsutake, Kotaro
    Ueda, Yasuharu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (02) : 160 - 168